Quincy Bioscience/Prevagen® Memory Supplement False Advertising – Class Action Investigation
Chimicles & Tikellis LLP is investigating a potential class action lawsuit against Quincy Bioscience, the makers of the memory supplement Prevagen® (“Prevagen”), following reports that the product is falsely marketed advertised and provides no real memory benefit to consumers.
Prevagen is marketed as “a memory enhancing supplement based on glowing jellyfish protein” that can improve memory, provide cognitive benefits, and has been advertised as “clinically shown” to work. The extensive national advertising campaign for Prevagen – including TV spots on national broadcast and cable networks such as CNN, Fox News, and NBC – feature charts depicting rapid and dramatic improvement in memory for users of the product.
However, it is alleged that marketing of Prevagen has relied on a study that failed to show that Prevagen works better than a placebo on any measure of cognitive function. The Federal Trade Commission and the New York State Attorney General recently made the decision to charge Quincy Bioscience for making false and unsubstantiated claims following a memory study that failed to demonstrate any of these benefits in Prevagen, with the New York Attorney General even calling Prevagen marketing practices “clear-cut fraud.”
These marketing and advertising practices may be in violation of state and federal consumer protection laws. If you have purchased Prevagen from Quincy Bioscience, please contact the lawyers listed on this page, as you may be entitled to compensation.